China National Pharmaceutical Group Co. Ltd.

Sinopharm Group Co. Ltd. agreed to acquire a 60% equity interest in China National Scientific Instruments and Materials Co. Ltd. from its controlling shareholder for RMB 5.11 billion, to strengthen its medical device business.